by Vora Corporate Finance | Mar 9, 2024 | Insights, Merger & Acquisitions
Transaction: Eris Lifesciences Ltd., a leading Indian branded formulations company, today announced the expansion of its Sterile Injectable footprint through the acquisition of 51% equity stake in Swiss Parenterals Ltd. for a consideration of Rs 637.50 Crore. This...
by Vora Corporate Finance | Feb 24, 2024 | Articles, Capital Market Updates
IMF in a report gave fairly optimistic outlook for Indian Economy. (COP28, the 28th annual United Nations (UN) climate meeting, was held in Dubai, where governments of 200 nations discussed how to limit and prepare for future climate change.) For the first time all...
by Vora Corporate Finance | Feb 24, 2024 | Insights, Private Equity & IPO
PE: Byjus to raise funds at a discount of over 90% from its previous valuation. Transaction: Beleaguered edtech startup Byju’s is looking at raising fresh funds at a discount of over 90 per cent from its previous valuation to get rid of its financial problems....
by Vora Corporate Finance | Feb 24, 2024 | Insights, Merger & Acquisitions
M&A: Sony terminates merger deal with Zee Entertainment Transaction: Sony pictures entertainment gave a statement confirming sending termination notice to Zee Entertainment Enterprise Ltd., ending proposed $10 billion merger in India. Sony served the termination...
by Vora Corporate Finance | Feb 24, 2024 | Insights
Secondary Market: The BSE Sensex closed at71,752.11 by -0.68% and the Nifty 50 closed at 21,725.70 by -0.03% in the month of January 2024. There’s a noticeable rally in cyclical stocks, driven by the broader economic outlook and expectations of growth. The increased...
